The article discusses the efficacy of skeletal muscle relaxants (SMRs) and how and when they should be prescribed. Topics discussed include the adverse risks of SMRs, the relevance of in-person reassessment before renewing SMR prescription, and types of SMRs, their prescription as antispasticity agents for children with hypertonicity from conditions such as cerebral palsy.